Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

Ralph L Sacco, Hans-Christoph Diener, Salim Yusuf, Daniel Cotton, Stephanie Ounpuu, William A Lawton, Yuko Palesch, Reneé H Martin, Gregory W Albers, Philip Bath, Natan Bornstein, Bernard P L Chan, Sien-Tsong Chen, Luis Cunha, Björn Dahlöf, Jacques De Keyser, Geoffrey A Donnan, Conrado Estol, Philip Gorelick, Vivian GuKarin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lu, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam Vandermaelen, Thor Voigt, Michael Weber, Byung-Woo Yoon, PRoFESS Study Group, Peter Passmore

Research output: Contribution to journalArticle

704 Citations (Scopus)

Abstract

Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens--aspirin plus extended-release dipyridamole (ASA-ERDP) versus clopidogrel.
Original languageEnglish
Pages (from-to)1238-51
Number of pages14
JournalNew England Journal of Medicine
Volume359
Issue number12
DOIs
Publication statusPublished - 18 Sep 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke'. Together they form a unique fingerprint.

  • Cite this

    Sacco, R. L., Diener, H-C., Yusuf, S., Cotton, D., Ounpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., Bornstein, N., Chan, B. P. L., Chen, S-T., Cunha, L., Dahlöf, B., De Keyser, J., Donnan, G. A., Estol, C., Gorelick, P., ... Passmore, P. (2008). Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. New England Journal of Medicine, 359(12), 1238-51. https://doi.org/10.1056/NEJMoa0805002